106 related articles for article (PubMed ID: 15618689)
21. Non-synonymous single nucleotide alterations found in the CYP2C8 gene result in reduced in vitro paclitaxel metabolism.
Soyama A; Saito Y; Hanioka N; Murayama N; Nakajima O; Katori N; Ishida S; Sai K; Ozawa S; Sawada JI
Biol Pharm Bull; 2001 Dec; 24(12):1427-30. PubMed ID: 11767116
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional insights into polymorphic enzymes of cytochrome P450 2C8.
Jiang H; Zhong F; Sun L; Feng W; Huang ZX; Tan X
Amino Acids; 2011 Apr; 40(4):1195-204. PubMed ID: 20848147
[TBL] [Abstract][Full Text] [Related]
23. Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants.
Melet A; Marques-Soares C; Schoch GA; Macherey AC; Jaouen M; Dansette PM; Sari MA; Johnson EF; Mansuy D
Biochemistry; 2004 Dec; 43(49):15379-92. PubMed ID: 15581350
[TBL] [Abstract][Full Text] [Related]
24. Novel mutations of the CYP2A6 gene in a Thai population with lowered capacity of coumarin 7-hydroxylation.
Kiyotani K; Yamazaki H; Fujieda M; Daigo S; Satarug S; Ujjin P; Kamataki T
Drug Metab Pharmacokinet; 2002; 17(2):161-3. PubMed ID: 15618666
[TBL] [Abstract][Full Text] [Related]
25. Novel single nucleotide polymorphism of UGT1A7 gene in Japanese.
Fujita K; Ando Y; Nagashima F; Yamamoto W; Endo H; Kodama K; Araki K; Miya T; Narabayashi M; Sasaki Y
Drug Metab Pharmacokinet; 2006 Feb; 21(1):75-8. PubMed ID: 16547397
[TBL] [Abstract][Full Text] [Related]
26. Novel single nucleotide polymorphism of UGT1A9 gene in Japanese.
Fujita K; Ando Y; Nagashima F; Yamamoto W; Endo H; Kodama K; Araki K; Miya T; Narabayashi M; Sasaki Y
Drug Metab Pharmacokinet; 2006 Feb; 21(1):79-81. PubMed ID: 16547398
[TBL] [Abstract][Full Text] [Related]
27. A major genotype in UDP-glucuronosyltransferase 2B15.
Toide K; Umeda S; Yamazaki H; Takahashi Y; Terauchi Y; Fujii T; Kamataki T
Drug Metab Pharmacokinet; 2002; 17(2):164-6. PubMed ID: 15618667
[TBL] [Abstract][Full Text] [Related]
28. Amiodarone N-deethylation by CYP2C8 and its variants, CYP2C8*3 and CYP2C8 P404A.
Soyama A; Hanioka N; Saito Y; Murayama N; Ando M; Ozawa S; Sawada J
Pharmacol Toxicol; 2002 Oct; 91(4):174-8. PubMed ID: 12530467
[TBL] [Abstract][Full Text] [Related]
29. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of CYP2C8.13 and CYP2C8.14: catalytic activities toward paclitaxel.
Hanioka N; Matsumoto K; Saito Y; Narimatsu S
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):565-9. PubMed ID: 20148860
[TBL] [Abstract][Full Text] [Related]
31. Novel nonsynonymous single nucleotide polymorphisms in the CYP2D6 gene.
Soyama A; Kubo T; Miyajima A; Saito Y; Shiseki K; Komamura K; Ueno K; Kamakura S; Kitakaze M; Tomoike H; Ozawa S; Sawada J
Drug Metab Pharmacokinet; 2004 Aug; 19(4):313-9. PubMed ID: 15499201
[TBL] [Abstract][Full Text] [Related]
32. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
[TBL] [Abstract][Full Text] [Related]
33. Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population.
Soyama A; Saito Y; Hanioka N; Maekawa K; Komamura K; Kamakura S; Kitakaze M; Tomoike H; Ueno K; Goto Y; Kimura H; Katoh M; Sugai K; Saitoh O; Kawai M; Ohnuma T; Ohtsuki T; Suzuki C; Minami N; Kamatani N; Ozawa S; Sawada J
Drug Metab Pharmacokinet; 2005 Feb; 20(1):24-33. PubMed ID: 15770072
[TBL] [Abstract][Full Text] [Related]
34. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.
Niemi M; Backman JT; Kajosaari LI; Leathart JB; Neuvonen M; Daly AK; Eichelbaum M; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2005 Jun; 77(6):468-78. PubMed ID: 15961978
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of CYP2C8 polymorphisms in a North Indian population.
Minhas S; Setia N; Pandita S; Saxena R; Verma IC; Aggarwal S
Genet Mol Res; 2013 Jul; 12(3):2260-6. PubMed ID: 23884769
[TBL] [Abstract][Full Text] [Related]
36. Differential contribution of active site residues in substrate recognition sites 1 and 5 to cytochrome P450 2C8 substrate selectivity and regioselectivity.
Kerdpin O; Elliot DJ; Boye SL; Birkett DJ; Yoovathaworn K; Miners JO
Biochemistry; 2004 Jun; 43(24):7834-42. PubMed ID: 15196026
[TBL] [Abstract][Full Text] [Related]
37. Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.
Rao DK; Murthy DK; Shaik NS; Banaganapalli B; Konda K; Rao HP; Ganti E; Ahmed Awan Z; A El-Harouni A; Elango R; Ali Khan I; Shaik NA
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1171-1179. PubMed ID: 28686288
[TBL] [Abstract][Full Text] [Related]
38. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.
Dai D; Zeldin DC; Blaisdell JA; Chanas B; Coulter SJ; Ghanayem BI; Goldstein JA
Pharmacogenetics; 2001 Oct; 11(7):597-607. PubMed ID: 11668219
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
